GET IN TOUCH

Biologics Developability Assessment and Analytical Testing

Assessment data generated to support candidate evaluation and clinical development planning.

Aragen Life Sciences assesses whether biologic drug candidates can be developed and manufactured, and provides the analytical tests to characterize them.

Developability assessment looks for properties such as aggregation, post-translational modifications, stability and solubility. These can affect safety, efficacy and manufacturability. We combine in silico modeling with stress, stability and concentration tests.

Early results help teams plan process controls before preclinical studies and avoid costly formulation work.

Analytical testing at a glance

Test areaWhat it tells youMethods
Protein activityWhether the protein does what it shouldBinding affinity (Octet RED96, Biacore 3000), enzyme activity, cell-based assays, in vivo testing
Titer and concentrationHow much protein is presentProtein A HPLC, ELISA, A280
Integrity and structureSize, charge and hydrophobic variants, purity, glycans and impuritiesSEC-HPLC, SEC-MALS, CE-SDS, RP-HPLC/UPLC, HIC, cIEF, SDS-PAGE, HILIC-FLD and CE glycan analysis, Western blot, HCP ELISA, endotoxin (LAL)
StabilityHow the protein resists heat and aggregationTm and Tagg, ΔG, isothermal stability, thermal recovery, sizing and polydispersity, B22 and kD, viscosity (Unchained Labs Uncle)
MassAccurate mass, modifications and mappingAccurate mass of proteins and protein-drug conjugates, peptide and glycan mapping, post-translational modification analysis, standard certificates of analysis (Agilent HPLC-CHIP/QTOF)

 
We offer:

Protein
Activity

  • Binding affinity (FortéBio Octet® RED96 System, GE Biacore™ 3000)
  • Enzyme activity
  • Cell-based assays
  • In vivo testing

Protein Titer/Concentration

  • Protein A HPLC
  • ELISA
  • A280

Protein Integrity & Structure

  • Size variants by SEC-HPLC
  • Size variants by SEC-MALS
  • Size variants by CE-SDS (reduced and non-reduced)
  • Hydrophobic variants by RP-HPLC/UPLC or HIC
  • Protein purity by SDS-PAGE
  • N-glycan analysis by HILIC-FLD
  • N-glycan analysis by CE
  • Sialic acid content by DMB RP
  • Free thiol content by SEC-FLD
  • Charge variants by cIEF
  • Western Blot
  • HCP titer by ELISA
  • Residual Protein A, Protein G, Protein L by ELISA or Octet
  • Endotoxin levels by LAL

Protein Stability (Unchained Labs: Uncle)

  • Tm and Tagg
  • △G
  • Isothermal stability
  • Thermal recovery
  • Sizing and polydispersity
  • Sizing with thermal ramp
  • B22 and kD
  • Viscosity

Protein mass (Agilent HPLC- CHIP/QTOF)

  • Accurate mass: proteins, protein-drug conjugates
  • Peptide and Glycan mapping
  • Determination of post-translation modifications either in known or unknown samples
  • Standard COAs
Frequently Asked Questions (FAQs)

Developability assessment tests a drug candidate for properties, such as aggregation and stability, that can affect manufacturability and clinical success.

Yes. Aragen performs accurate mass analysis of proteins and protein-drug conjugates.

A certificate of analysis (CoA) lists test results for a batch.